1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism

被引:77
作者
Storch, A [1 ]
Kaftan, A [1 ]
Burkhardt, K [1 ]
Schwarz, J [1 ]
机构
[1] Univ Ulm, Dept Neurol, Sch Med, D-89081 Ulm, Germany
关键词
salsolinol; 1-methyl-4-phenylpyridinium (MPP+); neurotoxicity; Parkinson's disease; energy metabolism;
D O I
10.1016/S0006-8993(99)02272-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The endogenous neurotoxin 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol), which is structurally similar to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), has been reported to inhibit mitochondrial complex I(NADH-Q reductase) activity as does the MPTP metabolite 1-methyl-3-phenylpyridinium ion (MPP+). However, the mechanism of salsolinol leading to neuronal cell death is still unknown. Thus, we correlated indices of cellular energy production and cell viability in human dopaminergic neuroblastoma SH-SY5Y cells after exposure to salsolinol and compared these results with data obtained with MPP+. Both toxins induce time and dose-dependent decrease in cell survival with IC50 values of 34 mu M and 94 mu M after 72 h for salsolinol and MPP+, respectively. Furthermore, salsolinol and MPP+ produce a decrease of intracellular net ATP content with IC50 values of 62 mu M and 66 mu M after 48 h, respectively. In contrast to MPP+, salsolinol does not induce an increase of intracellular net NADH content. Ln addition, enhancing glycolysis by adding D-glucose to the culture medium protects the cells against MPP+ but not salsolinol induced cellular ATP depletion and cytotoxicity. These results suggest that cell death induced by salsolinol is due to impairment of cellular energy supply, caused in particular by inhibition of mitochondrial complex II (succinate-Q reductase), but not complex I. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 53 条
[31]   A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol [J].
Naoi, M ;
Maruyama, W ;
Dostert, P ;
Kohda, K ;
Kaiya, T .
NEUROSCIENCE LETTERS, 1996, 212 (03) :183-186
[32]  
Naoi M, 1998, J NEURAL TRANSM-SUPP, P125
[33]  
NAPPI AJ, 1999, IN PRESS NEUROTAXIC
[34]   INHIBITION OF NADH-LINKED OXIDATION IN BRAIN MITOCHONDRIA BY 1-METHYL-4-PHENYL-PYRIDINE, A METABOLITE OF THE NEUROTOXIN, 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE [J].
NICKLAS, WJ ;
VYAS, I ;
HEIKKILA, RE .
LIFE SCIENCES, 1985, 36 (26) :2503-2508
[35]  
RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
[36]   NADH in the pyramidal cell layer of hippocampal regions CA1 and CA3 upon selective inhibition and uncoupling of oxidative phosphorylation [J].
Riepe, MW ;
Schmalzigaug, K ;
Fink, F ;
Oexle, K ;
Ludolph, AC .
BRAIN RESEARCH, 1996, 710 (1-2) :21-27
[37]  
Rommelspacher H, 1985, Prog Drug Res, V29, P415
[38]  
ROSS RA, 1985, CANCER RES, V45, P1628
[39]   TETRAHYDROISOQUINOLINE ALKALOIDS - IN-VIVO METABOLITES OF L-DOPA IN MAN [J].
SANDLER, M ;
CARTER, SB ;
HUNTER, KR ;
STERN, GM .
NATURE, 1973, 241 (5390) :439-443
[40]   MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSONS-DISEASE [J].
SCHAPIRA, AHV ;
COOPER, JM ;
DEXTER, D ;
CLARK, JB ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (03) :823-827